
Bausch Health Companies Inc.
BHC·TSX
Last updated as of 2026-04-02 24:39 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
BHC stock price change
On the last trading day, BHC stock closed at 7.76 CAD, with a price change of 3.19% for the day.
Trade stock perpsTrending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreBHC key data
Previous close7.76 CAD
Market cap2.79B CAD
Volume304.40K
P/E ratio13.88
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)0.56 CAD
Net income (FY)219.37M CAD
Revenue (FY)14.34B CAD
Next report dateApr 30, 2026
EPS estimate0.930 CAD
Revenue estimate3.30B CAD CAD
Shares float327.11M
Beta (1Y)1.63

Bausch Health Companies Inc. overview
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.
Sector
Health technology
Industry
Pharmaceuticals: Other
CEO
Thomas J. Appio
Headquarters
Laval
Website
bauschhealth.com
Founded
1994
Employees (FY)
20.3K
Change (1Y)
−400 −1.93%
Revenue / Employee (1Y)
706.63K CAD
Net income / Employee (1Y)
10.81K CAD
BHC stock price forecast
According to technical indicators for BHC stock, the price is likely to fluctuate within the range of 7.04–9.37 CAD over the next week. Market analysts predict that the price of BHC stock will likely fluctuate within the range of 6.44–9.63 CAD over the next months.
Based on 1-year price forecasts from 54 analysts, the highest estimate is 20.66 CAD, while the lowest estimate is 7.44 CAD.
For more information, please see the
BHC stock price forecast
page.
Latest BHC stock news
Here's Walmart's hidden $1 trillion strategy
101 finance2026-02-22 13:33:17
Globus Medical (GMED) Reports Earnings Tomorrow: What To Expect
Finviz2026-02-23 03:15:41
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
Finviz2026-02-23 21:42:40
5 Insightful Analyst Inquiries from Bausch + Lomb’s Fourth Quarter Earnings Call
101 finance2026-02-25 09:57:38
Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth
Finviz2026-02-27 10:15:01
2 Lucrative Stocks to Consider and 1 We Choose to Overlook
101 finance2026-03-05 13:28:15
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
Finviz2026-03-09 12:03:09
Teladoc (TDOC) Jumps 5.1%: Does This Signal More Upside Ahead?
101 finance2026-03-11 11:03:50
Bausch (BHC) Shares Fall 15.2% After Last
101 finance2026-03-20 16:33:50
Bausch + Lomb Shares Fall Despite Positive ELIOS Trial Results—Is the Market Overlooking Regulatory Concerns or Missing the Potential Impact?
101 finance2026-03-24 03:33:58
Baker Hughes Stakes Its Future on the Physical Rails of AI and Carbon Capture Growth
101 finance2026-03-24 08:33:58
miraDry Sees 34% Jump in Patient Spending: Has the Market Already Priced in the Growth?
101 finance2026-03-24 14:48:42
Is the Options Market Signaling a Surge for Bausch Health Shares?
101 finance2026-03-24 21:39:48
SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update
Finviz2026-03-26 20:09:55
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026
Finviz2026-03-31 11:03:09
Here's Walmart's hidden $1 trillion strategy
101 finance2026-02-22 13:33:17
Globus Medical (GMED) Reports Earnings Tomorrow: What To Expect
Finviz2026-02-23 03:15:41
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
Finviz2026-02-23 21:42:40
5 Insightful Analyst Inquiries from Bausch + Lomb’s Fourth Quarter Earnings Call
101 finance2026-02-25 09:57:38
Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth
Finviz2026-02-27 10:15:01
2 Lucrative Stocks to Consider and 1 We Choose to Overlook
101 finance2026-03-05 13:28:15




